Home > About us > The latest News
Akston Biosciences and TRACER Announce Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate
Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine
Annexin Pharmaceuticals AB Initiates Collaboration with TRACER to Perform In-Human Imaging Studies
TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452, an innovative anti-COVID-19 vaccine
Unique Profit-Free Consortium Releases ImmediateCapacity and Infrastructure to Accelerate COVID-19 Treatments and Vaccine Research
